TCL Archive The Line Item for Cancer Centers and SPOREs to Remain Flat, Near $598 Million for the 2013 Fiscal Year April 20, 2012
TCL Archive Appeals Court Overturns FDA Approval Of Generic Paclitaxel, A Setback For Ivax. November 9, 2001